sulforaphane has been researched along with Fra(X) Syndrome in 1 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Napoli, E | 1 |
Flores, A | 1 |
Mansuri, Y | 1 |
Hagerman, RJ | 1 |
Giulivi, C | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers[NCT05233579] | 15 participants (Actual) | Interventional | 2021-06-25 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for sulforaphane and Fra(X) Syndrome
Article | Year |
---|---|
Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome.
Topics: Aged; Aged, 80 and over; Ataxia; Energy Metabolism; Female; Fibroblasts; Fragile X Syndrome; Humans; | 2021 |